Iridex to Present at the 35th Annual Roth Conference
March 07, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
Viridian Therapeutics Announces Presentations at the 49th Annual Meeting of the North American Neuro-Ophthalmology Society
March 07, 2023 08:00 ET
|
Viridian Therapeutics, Inc
- Data from ongoing Phase 1/2 trial of VRDN-001 to be presented during oral platform session - - Additional poster presentations to cover trial design, early-stage clinical and mechanistic data...
Ocular Implants Market Poised To Hold The Value Of USD 24.3 Billion by 2032 - Market.us
March 06, 2023 15:26 ET
|
Market.Us
New York, March 06, 2023 (GLOBE NEWSWIRE) -- The global ocular implants market was worth USD 14 billion in 2022. Ocular Implants Market Set for Explosive Growth, To Reach Around USD 24.3 Billion by...
Oculis Announces US Public Listing on NASDAQ
March 03, 2023 07:00 ET
|
Oculis
Oculis Announces US Public Listing on NASDAQ Closing of business combination with European Biotech Acquisition Corp. creates Nasdaq-listed ophthalmology company, under the ticker “OCS”, with advanced...
Iridex Introduces New Research and Showcases Five Events at the AGS Meeting
March 02, 2023 09:00 ET
|
IRIDEX Corporation
Five Events at Booth #5 Discover the latest surgical techniques and outcomes published by the International MicroPulse TLT Consensus Panel.Watch Dr. Syril Dorairaj’s e-poster on prospective...
argenx Announces Planned Transition of Chief Operating Officer
March 02, 2023 01:00 ET
|
argenx SE
Karen Massey appointed as Chief Operating Officer, effective March 13, 2023Keith Woods to retire and serve as Advisor on argenx Board of Directors March 2, 2023 Amsterdam, the Netherlands — argenx...
Syneos Health Unveils New Decentralized Clinical Trial Site Network to Drive DCT Adoption
February 28, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of a Decentralized...
GLOBAL DOWN SYNDROME FOUNDATION RECEIVES GRANT TO CORRECT SERIOUS EYE ISSUES & VISION LOSS IN PATIENTS WITH DOWN SYNDROME
February 27, 2023 15:00 ET
|
Global Down Syndrome Foundation
Denver, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Global Down Syndrome Foundation (GLOBAL) announced today that it has received a transformative grant from The Salah Foundation. The grant will fund three...
Levation Pharma Initiates Phase I/II Clinical Trial of LEV102 for Acquired Blepharoptosis
February 27, 2023 08:00 ET
|
Levation Pharma
LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Levation Pharma Ltd., a pharmaceutical company focused on the development of new therapeutics for the ophthalmology and aesthetic space, received FDA...
Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
February 23, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...